AR058738A1 - Hidrazida del acido imidazo (1,2-a) piridin -3-il- acetico, procedimientos para su preparacion, usos de la misma y composicion farmaceutica que la comprende - Google Patents
Hidrazida del acido imidazo (1,2-a) piridin -3-il- acetico, procedimientos para su preparacion, usos de la misma y composicion farmaceutica que la comprendeInfo
- Publication number
- AR058738A1 AR058738A1 ARP060105781A ARP060105781A AR058738A1 AR 058738 A1 AR058738 A1 AR 058738A1 AR P060105781 A ARP060105781 A AR P060105781A AR P060105781 A ARP060105781 A AR P060105781A AR 058738 A1 AR058738 A1 AR 058738A1
- Authority
- AR
- Argentina
- Prior art keywords
- optionally substituted
- group
- cycloalkyl
- straight
- chain alkyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P23/00—Anaesthetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Anesthesiology (AREA)
- Pain & Pain Management (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Abstract
Y las correspondientes sales farmacéuticamente aceptables, polimorfos, hidratos, tautomeros, solvatos y estereoisomeros. Los compuestos de formula (1) son utiles para tratar o prevenir, en seres humanos y animales mamíferos, las enfermedads asociadas con la modulacion de los receptores GABAA, ansiedad, epilepsia, trastornos del sueno incluyendo el insomnio, y para inducir sedacion-hipnosis, anestesia, sueno y relajacion muscular. La presente también proporciona procedimientos de síntesis para preparar dichos compuetsos. Reivindicacion 1: Una hidrazida del ácido imidazo[1,2-a]piridin-3-il-acético, caracterizada porque es de formula (1) donde R1 se selecciona del grupo que consiste en H, alquil C1-6 de cadena lineal o ramificada, alquenil C2-6, alquinil C2-6 y cicloalquil C3-6; R2 y R3 se seleccionan indepedientemente del grupo que consiste en H, alquil C1-6 de cadena lineal o ramificada, alquenil C2-6, alquinil C2-6, cicloalquil C3-6 y R4CO, o bien R2 y R3 pueden formar, junto con el átomo de N al cual están unidos, un anillo heterocíclico de 5-6 miembros opcionalmente sustituido, o un grupo NCR5R6; R4 se selecciona del grupo que consiste en alquil C1-6 de cadena lineal o ramificada, cicloalquil C3-6, aril opcionalmente sustituido y heteroaril opcionalmente sustituido; R5 se selecciona del grupo que consiste en , alquil C1-6 de cadena lineal o ramificada, cicloalquil C3-6 y aril opcionalmente sustituido; R6 se selecciona del grupo que consiste en alquil C1-6 de cadena lineal o ramificada, cicloalquil C3-6 y aril opcionalmente sustituido, o bien R5 y R6 pueden formar, junto con el átomo de C al cual están unidos, un anillo de 5-6 miembros opcionalmente sustituido; y las respectivas sales farmacéuticamente aceptables, polimorfos, hidratos, tautomeros, solvatos, y estereoisomeros.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP06100030A EP1803722A1 (en) | 2006-01-03 | 2006-01-03 | Imidazo[1,2-a]pyridin-3-yl-acetic acid hydrazides, processes for their preparation and pharmaceutical uses thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
AR058738A1 true AR058738A1 (es) | 2008-02-20 |
Family
ID=36691692
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP060105781A AR058738A1 (es) | 2006-01-03 | 2006-12-26 | Hidrazida del acido imidazo (1,2-a) piridin -3-il- acetico, procedimientos para su preparacion, usos de la misma y composicion farmaceutica que la comprende |
Country Status (23)
Country | Link |
---|---|
US (2) | US7943611B2 (es) |
EP (2) | EP1803722A1 (es) |
JP (1) | JP2009522327A (es) |
KR (1) | KR20080083194A (es) |
CN (1) | CN101395156B (es) |
AR (1) | AR058738A1 (es) |
AT (1) | ATE430748T1 (es) |
AU (1) | AU2006334364B2 (es) |
BR (1) | BRPI0620885A2 (es) |
CA (1) | CA2635802A1 (es) |
DE (1) | DE602006006725D1 (es) |
DK (1) | DK1973907T3 (es) |
ES (1) | ES2327278T3 (es) |
HK (1) | HK1123792A1 (es) |
IL (1) | IL192563A0 (es) |
NO (1) | NO20083304L (es) |
PE (1) | PE20071059A1 (es) |
PL (1) | PL1973907T3 (es) |
PT (1) | PT1973907E (es) |
RU (1) | RU2008131798A (es) |
TW (1) | TW200800992A (es) |
UY (1) | UY30066A1 (es) |
WO (1) | WO2007077159A1 (es) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1845098A1 (en) * | 2006-03-29 | 2007-10-17 | Ferrer Internacional, S.A. | Imidazo[1,2-b]pyridazines, their processes of preparation and their use as GABA receptor ligands |
CN109053726A (zh) * | 2018-09-14 | 2018-12-21 | 烟台万润药业有限公司 | 一种唑吡坦酸的制备方法 |
KR102349934B1 (ko) | 2020-10-19 | 2022-01-12 | 신해찬 | 층간소음방지부재 및 이를 이용한 층간소음방지층 시공방법 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU532001B2 (en) * | 1978-11-20 | 1983-09-15 | Sumitomo Chemical Company, Limited | Polycyclic indole derivatives |
FR2492382A1 (fr) * | 1980-10-22 | 1982-04-23 | Synthelabo | Derives d'imidazo (1,2-a) pyridine, leur preparation et leur application en therapeutique |
ES2151834B1 (es) * | 1998-08-06 | 2001-08-16 | Sint Quimica Sa | Procedimiento para preparar n,n,6-trimetil-2-(4-metilfenil)-imidazo-(1,2-a)-piridina-3-acetamida y sus sales. |
CA2544213A1 (en) * | 2003-10-28 | 2005-05-19 | Sepracor Inc. | Imidazo[1,2-a]pyridine anxiolytics |
-
2006
- 2006-01-03 EP EP06100030A patent/EP1803722A1/en not_active Withdrawn
- 2006-12-21 RU RU2008131798/04A patent/RU2008131798A/ru unknown
- 2006-12-21 BR BRPI0620885-1A patent/BRPI0620885A2/pt not_active IP Right Cessation
- 2006-12-21 DK DK06841585T patent/DK1973907T3/da active
- 2006-12-21 KR KR1020087018796A patent/KR20080083194A/ko not_active Application Discontinuation
- 2006-12-21 PL PL06841585T patent/PL1973907T3/pl unknown
- 2006-12-21 AT AT06841585T patent/ATE430748T1/de active
- 2006-12-21 WO PCT/EP2006/070130 patent/WO2007077159A1/en active Application Filing
- 2006-12-21 JP JP2008548979A patent/JP2009522327A/ja not_active Ceased
- 2006-12-21 EP EP06841585A patent/EP1973907B1/en not_active Not-in-force
- 2006-12-21 AU AU2006334364A patent/AU2006334364B2/en not_active Ceased
- 2006-12-21 US US12/087,423 patent/US7943611B2/en not_active Expired - Fee Related
- 2006-12-21 ES ES06841585T patent/ES2327278T3/es active Active
- 2006-12-21 DE DE602006006725T patent/DE602006006725D1/de active Active
- 2006-12-21 CA CA002635802A patent/CA2635802A1/en not_active Abandoned
- 2006-12-21 CN CN2006800536332A patent/CN101395156B/zh not_active Expired - Fee Related
- 2006-12-21 PT PT06841585T patent/PT1973907E/pt unknown
- 2006-12-22 PE PE2006001689A patent/PE20071059A1/es not_active Application Discontinuation
- 2006-12-26 UY UY30066A patent/UY30066A1/es unknown
- 2006-12-26 AR ARP060105781A patent/AR058738A1/es not_active Application Discontinuation
- 2006-12-27 TW TW095149148A patent/TW200800992A/zh unknown
-
2008
- 2008-07-01 IL IL192563A patent/IL192563A0/en unknown
- 2008-07-25 NO NO20083304A patent/NO20083304L/no not_active Application Discontinuation
-
2009
- 2009-02-18 HK HK09101530.6A patent/HK1123792A1/xx not_active IP Right Cessation
-
2011
- 2011-01-24 US US13/012,258 patent/US20110118256A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
PL1973907T3 (pl) | 2009-10-30 |
AU2006334364B2 (en) | 2011-09-29 |
AU2006334364A1 (en) | 2007-07-12 |
US20110118256A1 (en) | 2011-05-19 |
BRPI0620885A2 (pt) | 2011-11-29 |
CN101395156A (zh) | 2009-03-25 |
EP1803722A1 (en) | 2007-07-04 |
DE602006006725D1 (de) | 2009-06-18 |
UY30066A1 (es) | 2007-04-30 |
NO20083304L (no) | 2008-09-24 |
JP2009522327A (ja) | 2009-06-11 |
CA2635802A1 (en) | 2007-07-12 |
DK1973907T3 (da) | 2009-08-24 |
ATE430748T1 (de) | 2009-05-15 |
EP1973907B1 (en) | 2009-05-06 |
EP1973907A1 (en) | 2008-10-01 |
CN101395156B (zh) | 2011-12-14 |
PT1973907E (pt) | 2009-07-28 |
IL192563A0 (en) | 2009-02-11 |
ES2327278T3 (es) | 2009-10-27 |
WO2007077159A1 (en) | 2007-07-12 |
US7943611B2 (en) | 2011-05-17 |
KR20080083194A (ko) | 2008-09-16 |
US20090176777A1 (en) | 2009-07-09 |
PE20071059A1 (es) | 2007-10-26 |
TW200800992A (en) | 2008-01-01 |
RU2008131798A (ru) | 2010-02-10 |
HK1123792A1 (en) | 2009-06-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HRP20171565T1 (hr) | C17-heteroaril derivati oleanolne kiseline i postupci njihove uporabe | |
AR060212A1 (es) | Compuestos de imidazo (1,2-b) piridacinas, procesos para su preparacion y de sus intermedios; usos de dichos compuestos; y composicion farmaceutica que los comprende | |
AR079327A1 (es) | Derivados de 2-amino-5,5-difluor -5,6-dihidro-4h-(1,3) oxazin-4-il) fenil)-amida | |
UY31730A (es) | Derivados polisustituidos de 6-heteroaril-imidazo[1,2-a]piridinas, su preparación y su aplicación en terapéutica. | |
ECSP024393A (es) | Derivados biciclicos sustituidos para el tratamiento del crecimiento celular normal | |
AR036604A1 (es) | Derivados de 4-pirimidona 3-sustituida | |
AR046297A1 (es) | Inhibidores de la dpp - iv metodos para prepararlos y composiciones farmaceuticas que los contienen como agente activo | |
UY31727A (es) | Derivados polisustituidos de 2-aril-6-fenil-imidazo[1,2-a]piridinas, su preparación y su aplicación en terapéutica | |
AR085960A1 (es) | 1,3-oxazinas como inhibidores de la bace1 y/o de la bace2 | |
NO20073357L (no) | 5-karboksamid substituerte tiazol derivater som reagerer med ionekanaler, i saerdeleshet med ionekanaler fra Kv familien | |
ECSP13012611A (es) | Derivados de pirazol-aminopirimidina como moduladores de la lrrk2 | |
AR084849A1 (es) | Derivados de oxazina y su uso en el tratamiento de trastornos neurologicos | |
UY28376A1 (es) | Agentes terapéuticos | |
DOP2006000169A (es) | Inhibidores espiropiperidina de beta-secretasa para el tratamiento de la enfermedad de alzheimer | |
UY29766A1 (es) | Formas cristalinas delta y épsilon de mesilato de imatinib | |
UY29838A1 (es) | Derivados sustituidos de 4,5,6,7-tetrahidropirrolo(3,2,c)piridin-4-ona y de 4,5-tetrahidropirrolo(3,2,c)piridin-4-ona, composiciones farmacéuticas conteniéndolos, procesos de preparación y aplicaciones | |
EA201001365A1 (ru) | ПРОИЗВОДНЫЕ ИМИДАЗО[1,2-b]ПИРИДАЗИНА, ПРЕДНАЗНАЧЕННЫЕ ДЛЯ ЛЕЧЕНИЯ ЗАБОЛЕВАНИЯ, ОПОСРЕДУЕМОГО C-МЕТ ТИРОЗИНКИНАЗОЙ | |
DOP2006000243A (es) | Derivados de pirazina | |
CO5690599A2 (es) | Derivados de 3-(4-aminofenil) tienopirimid-4-ona como antagonistas mch r1 para el tratamiento de obesidad, diabetes, depresion y ansiedad | |
AR054785A1 (es) | Compuesto que comprende pirazolo (1,5-a) pirimidinas halogenadas, procedimiento para prepararlo uso de dicho compuesto composicion farmaceutica que lo comprende, procedimiento para preparar sus intermedios y compuesto intermedio | |
MA30315B1 (fr) | Derives de 1,2,4,5-tetrahydro-3h-benzazepines, leur procede de preparation et les compositions pharmaceutiques qui les contiennent | |
BRPI0909782B8 (pt) | composto derivado de azetidina e composição farmacêutica compreendendo dito composto | |
AR051008A1 (es) | AMIDAS SUSTITUIDAS DE ACIDO TIENOPIRROLCARBOXILICO, AMIDAS DEL ACIDO PIRROLOTIAZOLCARBOXILICO Y ANALOGOS RELACIONADOS COMO INHIBIDORES DE LA CASEINA CINASA Ie | |
AR038404A1 (es) | Derivados de nicotinamida utiles como inhibidores de pde4, procedimiento para la preparacion del compuesto y composicion farmaceutica que lo incluye | |
AR084637A1 (es) | Compuestos heterociclicos apropiados para el tratamiento de la dislipidemia |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FA | Abandonment or withdrawal |